Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company
What level of growth is expected in the Small Volume Parenteral Market between 2026 and 2030?
The small volume parenteral market size has witnessed robust growth in recent years. This market is projected to expand from $191.36 billion in 2025 to $207.18 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 8.3%. Historically, this growth has been driven by factors such as the increasing adoption of injectable therapies, the broader reach of hospital-based drug administration, the widespread availability of glass ampule packaging, the rise in acute care treatments, and the growing need for parenteral nutrition.
The small volume parenteral market size is projected for substantial expansion over the upcoming years. This market is forecast to reach $275.99 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.4%. This anticipated growth during the forecast period is primarily driven by a greater need for biologics and vaccines, the increasing uptake of self-injectable treatments, an expansion of sterile manufacturing capabilities, a heightened emphasis on advanced drug delivery systems, and growing financial commitments to sterile packaging innovations. Key developments expected within the forecast timeframe encompass a rise in the use of prefilled syringe formats, an escalating need for sterile injectable medications, a broader application of single-dose parenterals, an expansion in the administration of vaccines and biologics, and an intensified focus on ensuring drug safety and stability.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15925&type=smp
Which Drivers Are Expected To Impact The Small Volume Parenteral Market During The Forecast Period?
The rising number of surgeries is projected to drive the expansion of the small-volume parenteral market in the future. Surgery is a medical discipline that uses operational techniques to investigate or treat a pathological state such as illness or injury, improve bodily capabilities or appearance, or repair unwanted ruptured areas. The frequency of surgeries is increasing because of advancements in medical technology and an aging population, which in turn raises the demand for surgical interventions. Small-volume parenteral solutions are utilized in surgeries to accurately deliver medications, electrolytes, and nutrients directly into the bloodstream. For instance, in June 2024, according to the American Society of Plastic Surgeons, a US-based non-profit organization, minimally invasive procedures grew by 7% in 2023, exceeding the growth rate of surgical procedures by 2%. Hand surgeries such as carpal tunnel, arthritis, and trigger finger amounted to 207,887 procedures, representing a 2% rise from 2022. Therefore, the increasing volume of surgeries is stimulating the growth of the small-volume parenteral market.
Which Segments Are Driving Activity In The Small Volume Parenteral Market?
The small volume parenteral market covered in this report is segmented –
1) By Type: Ampules, Vials, Prefilled Syringes
2) By Dose Type: Single Dose, Multiple Dose
3) By Indication Type: Pain Management, Cancer Care, Malnourishment, Gastrointestinal Disorders, Diabetes, Other Indications
4) By Application: Local Anesthetics, Vaccines, Other Applications
5) By End User: Hospitals, Clinics, Ambulatory Surgical Center, Other End Users
Subsegments:
1) By Ampules: Glass Ampules, Plastic Ampules
2) By Vials: Glass Vials, Plastic Vials, Single-dose Vials, Multi-dose Vials
3) By Prefilled Syringes: Glass Prefilled Syringes, Plastic Prefilled Syringes
How Are Emerging Trends Affecting The Progression Of The Small Volume Parenteral Market?
Leading companies within the small-volume parenteral market are prioritizing the creation of innovative solutions, such as prefilled, ready-to-use injectable formulations. These developments aim to improve dosing precision, minimize contamination risks, and enhance patient safety. Prefilled, ready-to-use injectable formulations are medications supplied pre-measured in a sterile syringe or vial, allowing healthcare providers to administer the drug directly without additional preparation. For instance, in June 2025, Gland Pharma Limited, an India-based generic injectable-focused pharmaceutical company, obtained approval from the U.S. Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Angiotensin II Acetate Injection 2.5 mg/mL. This injection is indicated for swiftly raising blood pressure in adults experiencing septic or distributive shock when conventional treatments prove insufficient. It functions by attaching to vascular smooth muscle receptors, initiating vasoconstriction and encouraging aldosterone release, with a rapid action that typically achieves target blood pressure within five minutes. Administered intravenously, the dose is precisely titrated to maintain the desired blood pressure, offering crucial assistance for patients who remain hypotensive despite fluid resuscitation and vasopressor therapy.
Which Leading Companies Dominate The Small Volume Parenteral Market Share?
Major companies operating in the small volume parenteral market are Pfizer Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, Novartis AG, GlaxoSmithKline plc, Eli Lilly and Company, Baxter International Inc., Teva Pharmaceutical Industries Ltd., Fresenius Kabi AG, Sun Pharmaceutical Industries Ltd., Boehringer Ingelheim GmbH, Viatris Inc, Intas Pharmaceuticals Ltd., Aurobindo Pharma Limited, Dr. Reddy’s Laboratories Ltd., Cipla Limited, Hikma Pharmaceuticals PLC, Lupin Limited, Biocon Limited, Torrent Pharmaceuticals Ltd., Zydus Cadila, Alembic Pharmaceuticals Ltd., Wockhardt Ltd.
Access The Complete Report For Deeper Market Insights:
https://www.thebusinessresearchcompany.com/report/small-volume-parenteral-global-market-report
Which Global Regions Are Shaping The Competitive Landscape Of The Small Volume Parenteral Market?
North America was the largest region in the small volume parenteral market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the small volume parenteral market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Small Volume Parenteral Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=15925&type=smp
Browse Through More Reports Similar to the Global Small Volume Parenteral Market 2026, By The Business Research Company
Parenteral Nutrition Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/parenteral-nutrition-global-market-report
Small Volume Parenteral Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/small-volume-parenteral-global-market-report
Large Volume Parenteral Lvp Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/large-volume-parenteral-lvp-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company